[1]
K. V. U. . Rao and N. . Shorgar, “Development of a stability-indicating UPLC method for quantification of mirvetuximab soravtansine-gynx in pharmaceutical formulations using quality by design (QbD) principles”, J. Appl. Pharm. Res., vol. 13, no. 2, pp. 204-213, Apr. 2025.